Factor viia, recombinant

Generic Medicine Info
Hypersensitivity to hamster, bovine or mouse proteins.
Special Precautions
Patient w/ conditions associated w/ circulating tissue factor (e.g. advanced atherosclerosis, crush injury or septicaemia) due to risk of precipitating thrombosis or disseminated intravascular coagulation. Pregnancy and lactation. Monitoring Parameters Monitor prothrombin time/INR, aPTT and factor VII clotting activity prior to and after therapy.
Adverse Reactions
Nausea, vomiting, skin reactions, fever, headache and changes in BP. Rarely, anaphylaxis.
Drug Interactions
Increased risk of thromboembolism w/ activated or non-activated prothrombin complex concentrate.
CIMS Class
Disclaimer: This information is independently developed by CIMS based on factor viia, recombinant from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2022 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in